Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia

Leukemia and Lymphoma

Volumn 46, Issue 3, 2005, Pages 393-399

  Kubuki, Yoko ^a   Suzuki, Muneou ^a   Sasaki, Hidenori ^a   Toyama, Takanori ^a   Yamashita, Kiyoshi ^a   Maeda, Koichi ^a   Ido, Akio ^a   Matsuoka, Hitoshi ^a   Okayama, Akihiko ^a   Nakanishi, Toshio ^b   Tsubouchi, Hirohito ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

ATL; Prognosis; Telomerase; Telomere

Indexed keywords

INTERLEUKIN 2 RECEPTOR; LACTATE DEHYDROGENASE; TELOMERASE; TUMOR MARKER;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL COUNT; CHRONIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKEMIA CELL; MALE; OUTCOMES RESEARCH; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; STATISTICAL ANALYSIS; SURVIVAL TIME; T CELL LEUKEMIA; TELOMERE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; VIRUS CARRIER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HTLV-I INFECTIONS; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RESTRICTION MAPPING; SEROLOGIC TESTS; SURVIVAL ANALYSIS; TELOMERASE; TELOMERE;

EID: 20844444747     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190400018349     Document Type: Article

References (33)

1. Greider CW. TL regulation. Ann Rev Biochem 1996;65:337-365.
2. Watson JD. Origin of concatemeric T7 DNA. Nature New Biology 1972;239:197-201.
3. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-1929.
4. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-573.
5. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW, et al. Telomerase, cell immortality, and cancer. Cold Spring Harbor Symposia Quantitative Biology 1994;59:307-315.
6. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015.
7. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, et al. The RNA component of human telomerase. Science 1995;269:1236-1241.
8. Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F. TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 1997;88:875-884.
9. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I, Robinson MO. A mammalian telomerase-associated protein. Science 1997;275:973-977.
10. Broccoli D, Young JW, Lange TD. Telomerase activity in normal and malignant hematopoietic cells. Proceedings of the National Academy of Sciences USA 1995;92:9082-9086.
11. Holt SE, Wright WE, Shay JW. Regulation of telomerase activity in immortal cell lines. Molecular and Cell Biology 1996;16:2932-2939.
12. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA, Shay JW. Telomerase activity in human breast tumors. Journal of the National Cancer Institute 1996;88:116-122.
13. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Detection of telomerase activity in malignant and nonmalignant skin conditions. The Journal of Investigative Dermatology 1996;106:759-765.
14. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. Journal of Immunology 1995;155:3711-3715.
15. Rhyu MS. Telomeres, telomerase, and immortality. Journal of National Cancer Institute 1995;87:884-894.
16. Autexier C, Greider CW. Telomerase and cancer: revisiting the telomere hypothesis. Trends in Biochemical Sciences 1996;21:387-391.
17. Holt SE, Shay JW, Wright WE. Refining the telomere-telomerase hypothesis of aging and cancer. Nature Biotechnology 1996;14:836-839.
18. Norton JC, Piatyszek MA, Wright WE, Shay JW, Corey DR. Inhibition of human telomerase activity by peptide nucleic acids. Nature Biotechnology 1996;14:615-619.
19. Shay JW, Werbin H, Wright WE. Telomeres and telomerase in human leukemias. Leukemia 1996;10:1255-1261.
20. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995;85:2315-2320.
21. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proceedings of the National Academy of Sciences USA 1994;91:2900-2904.
22. Takatsuki K, Matsuoka M, Yamaguchi K. ATL and HTLV-I-related diseases. In: Takatsuki K, editor. Adult T-cell leukemia. Oxford: Oxford University Press; 1994. p 1.
23. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of HTLV in all primary tumors of adult T-cell leukemia suggests causative role of HTLV in the disease. Proceedings of the National Academy of Sciences USA 1984;81:2534-2537.
24. Tajima K, Kuroishi T. Estimation of incidence rate of ATL among ATLV-carriers in Kyushu, Japan. Japanese Journal of Clinical Oncology 1985;15:423-430.
25. Takatsuki K, Yamaguchi K, Kawano F, Hattori T, Nishimura H, Tsuda H, Sanada I, Nakada K, Itai Y. Clinical diversity in adult T-cell leukemia/lymphoma. Cancer Research 1985;45(Suppl.):4644-4645.
26. Okamoto T, Ohno Y, Tsugane S, Watanabe S, Shimoyama M, Tajima K, Miwa M, Shimotohono K. Multi-step carcinogenesis model for adult T-cell leukemia. Japanese Journal of Cancer Research 1989;80:191-195.
27. Shimoyama M, and members of The Lymphoma Study Group. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma; a report from the lymphoma study group. British Journal of Haematology 1991;79:428-437.
28. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW, Matsuura Y. Telomerase activity in gastric cancer. Clinical Cancer Research 1995;55:3258-3262.
29. Shimoyama M, Ota K, Kikuchi M, Yunoki K, Konda S, Takatsuki K, Ichimaru M, Tominaga S, Tsugane S, Minato K, et al. Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. Journal of Clinical Oncology 1988;6:1088-1097.
30. Kamihira S, Atogami S, Sohda H, Momita S, Yamada Y, Tomonaga M. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer 1994;73:2753-2758.
31. Uchida N, Otsuka T, Arima F, Shigematsu H, Fukuyama T, Maeda M, Sugio Y, Itoh Y, Niho Y. Correlation of telomerase activity with development and progression o adult T-cell leukemia. Leukemia Research 1999;23:311-316.
32. Tatsumoto N, Hiyama E, Murakami Y, Imamura Y, Shay JW, Matsuura Y, Yokoyama T. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clinical Cancer Research 2000;6:2696-2701.
33. Shiratsuchi M, Muta K, Abe Y, Motomura S, Taguchi F, Takatsuki H, Uike N, Umemura T, Nawata H, Nishimura J. Clinical significance of telomerase activity in multiple myeloma. Cancer 2002;94:2232-2238.